ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

AKBA Akebia Therapeutics Inc

1,44
0,14 (10,77%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Akebia Therapeutics Inc AKBA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,14 10,77% 1,44 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,34 1,32 1,42 1,37 1,30
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:30PRNUSAkebia Therapeutics to Report First Quarter 2024 Financial..
01.5.202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
02.4.202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
28.3.202401:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
14.3.202421:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
11.3.202422:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
01.3.202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01.3.202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202422:32EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:28EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:27EDGAR2Form 144 - Report of proposed sale of securities
28.2.202400:19EDGAR2Form 144 - Report of proposed sale of securities
28.2.202400:14EDGAR2Form 144 - Report of proposed sale of securities
28.2.202400:11EDGAR2Form 144 - Report of proposed sale of securities
13.2.202414:00EDGAR2Form 8-K - Current report
02.2.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
01.2.202422:52EDGAR2Form 144 - Report of proposed sale of securities
30.1.202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
30.1.202414:05EDGAR2Form 8-K - Current report
30.1.202414:00PRNUSAkebia Secures $55 Million Term Loan Financing
18.1.202423:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
09.1.202414:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
08.1.202422:08EDGAR2Form 8-K - Current report
08.1.202414:02EDGAR2Form 8-K - Current report
02.1.202422:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
20.12.202314:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
18.12.202322:07EDGAR2Form 8-K - Current report
01.12.202322:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
21.11.202323:07EDGAR2Form 8-K - Current report
20.11.202314:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
08.11.202313:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202313:33EDGAR2Form 8-K - Current report
08.11.202313:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
02.11.202321:34EDGAR2Form 8-K - Current report
02.11.202321:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
01.11.202321:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock